Bromopyruvate/Salinomycin

N/A

Report date: 2024/01/04 09:20:53

Base Information

Drug NameBromopyruvate/Salinomycin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMannan-binding lectin serine protease 2 inhibitorsHexokinase type II inhibitorsPyruvate dehydrogenase complex inhibitors +[5] 
TargetsHexokinase type IIMannan-binding lectin serine protease 2Pyruvate dehydrogenase complex +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes BromopyruvateSalinomycin
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Treatment Institute Of Colombia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Treatment Institute Of Colombia
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A